Finance

Lists
Why is MRCK34 down 2,74%?
Dive Deeper
MRCK34:BVMF
Merck BDR
98,97 R$
-2,74%
(-2,79) 1D
19 նոյ, 18:05:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for MRCK34...
Open
101,62 R$
High
101,62 R$
Low
97,59 R$
Mkt. cap
329,65 մլրդ
Avg. vol.
5,43 հզր
Volume
0,00
52-wk high
108,55 R$
52-wk low
60,92 R$
Shares outstanding
2,47 մլրդ
No. of employees
74 հզր
Open
101,62 R$
High
101,62 R$
Low
97,59 R$
Mkt. cap
329,65 մլրդ
Avg. vol.
5,43 հզր
Volume
0,00
52-wk high
108,55 R$
52-wk low
60,92 R$
Shares outstanding
2,47 մլրդ
No. of employees
74 հզր
News stories
From web sources and news partners
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck BDR
CEORobert M Davis
Employees74 հզր
Founded1891 թ. հնվ 1
Headquarters-
SectorHealth Care
Industry-
Websitemerck.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
16,40 մլրդ
16,29 մլրդ
16,61 մլրդ
18,08 մլրդ
Cost of goods sold
4,30 մլրդ
3,88 մլրդ
4,13 մլրդ
4,41 մլրդ
Cost of revenue
4,30 մլրդ
3,88 մլրդ
4,13 մլրդ
4,41 մլրդ
Research and development expenses
4,00 մլրդ
3,56 մլրդ
9,74 մլրդ
4,54 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,73 մլրդ
2,57 մլրդ
2,78 մլրդ
2,77 մլրդ
Operating expense
6,73 մլրդ
6,12 մլրդ
12,52 մլրդ
7,30 մլրդ
Total operating expenses
11,02 մլրդ
10,00 մլրդ
16,65 մլրդ
11,72 մլրդ
Operating income
5,38 մլրդ
6,29 մլրդ
-40,00 մլն
6,37 մլրդ
Other non operating income
41,00 մլն
42,00 մլն
59,00 մլն
9,00 մլն
EBT including unusual items
3,42 մլրդ
-3,53 մլրդ
-683,00 մլն
5,56 մլրդ
EBT excluding unusual items
4,98 մլրդ
5,85 մլրդ
-508,00 մլն
5,82 մլրդ
Income tax expense
458,00 մլն
709,00 մլն
654,00 մլն
492,00 մլն
Effective tax rate
13,39%
-20,06%
-95,75%
8,85%
Other operating expenses
-
-
-
-
Net income
2,96 մլրդ
-4,24 մլրդ
-1,34 մլրդ
5,06 մլրդ
Net profit margin
18,07%
-26,03%
-8,04%
28,01%
Earnings per share
2,04
-1,28
-0,13
2,49
Interest and investment income
69,00 մլն
35,00 մլն
35,00 մլն
52,00 մլն
Interest expense
-411,00 մլն
-479,00 մլն
-525,00 մլն
-546,00 մլն
Net interest expenses
-342,00 մլն
-444,00 մլն
-490,00 մլն
-494,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
6,79 մլրդ
7,69 մլրդ
1,43 մլրդ
7,88 մլրդ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps